288 related articles for article (PubMed ID: 25877477)
1. Treatment of Clostridium difficile infection in a French university hospital.
Khanafer N; Blais L; Barbut F; Hirschel B; Vanhems P
Scand J Gastroenterol; 2015; 50(10):1253-60. PubMed ID: 25877477
[TBL] [Abstract][Full Text] [Related]
2. Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection.
Miller M; Bernard L; Thompson M; Grima D; Pepin J
Infect Control Hosp Epidemiol; 2010 Jul; 31(7):710-5. PubMed ID: 20518636
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, diagnosis and treatment of Clostridium difficile infection.
Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319
[TBL] [Abstract][Full Text] [Related]
4. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
Rokas KE; Johnson JW; Beardsley JR; Ohl CA; Luther VP; Williamson JC
Clin Infect Dis; 2015 Sep; 61(6):934-41. PubMed ID: 26024909
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
6. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
Le F; Arora V; Shah DN; Salazar M; Palmer HR; Garey KW
Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421
[TBL] [Abstract][Full Text] [Related]
7. Current strategies for management of initial Clostridium difficile infection.
Kelly CP
J Hosp Med; 2012 Mar; 7 Suppl 3():S5-10. PubMed ID: 22407996
[TBL] [Abstract][Full Text] [Related]
8. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
[TBL] [Abstract][Full Text] [Related]
9. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
[TBL] [Abstract][Full Text] [Related]
10. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
[TBL] [Abstract][Full Text] [Related]
11. [Clostridium difficile in visceral surgery].
Herzog T; Deleites C; Belyaev O; Chromik AM; Uhl W
Chirurg; 2015 Aug; 86(8):781-6. PubMed ID: 25432576
[TBL] [Abstract][Full Text] [Related]
12. Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
Robin C; Héquette-Ruz R; Guery B; Boyle E; Herbaux C; Galperine T
Med Mal Infect; 2017 Dec; 47(8):532-539. PubMed ID: 28823390
[TBL] [Abstract][Full Text] [Related]
13. Tigecycline for the treatment of severe Clostridium difficile infection.
Larson KC; Belliveau PP; Spooner LM
Ann Pharmacother; 2011 Jul; 45(7-8):1005-10. PubMed ID: 21730279
[TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
Bass SN; Bauer SR; Neuner EA; Lam SW
J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
[TBL] [Abstract][Full Text] [Related]
15. Meeting the challenge of recurrent Clostridium difficile infection.
Johnson S
J Hosp Med; 2012 Mar; 7 Suppl 3():S11-3. PubMed ID: 22407994
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
Pepin J
Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
[TBL] [Abstract][Full Text] [Related]
17. The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
Bishop EJ; Tiruvoipati R; Metcalfe J; Marshall C; Botha J; Kelley PG
Intern Med J; 2018 Jun; 48(6):651-660. PubMed ID: 29363242
[TBL] [Abstract][Full Text] [Related]
18. Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole.
Pham VP; Luce AM; Ruppelt SC; Wei W; Aitken SL; Musick WL; Roux RK; Garey KW
Antimicrob Agents Chemother; 2015 Oct; 59(10):6113-6. PubMed ID: 26195522
[TBL] [Abstract][Full Text] [Related]
19. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection.
Abbett SK; Yokoe DS; Lipsitz SR; Bader AM; Berry WR; Tamplin EM; Gawande AA
Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1062-9. PubMed ID: 19751156
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure.
Chilton CH; Crowther GS; Freeman J; Todhunter SL; Nicholson S; Longshaw CM; Wilcox MH
J Antimicrob Chemother; 2014 Feb; 69(2):451-62. PubMed ID: 24003182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
